Inappropriateness and variability of antibiotic prescription among French office-based physicians

Journal of Clinical Epidemiology

Volumn 51, Issue 1, 1998, Pages 61-68

  Guillemot, Didier ^a   Carbon, Claude ^b   Vauzelle Kervroëdan, Françoise ^a   Balkau, Beverley ^a   Maison, Patrick ^a   Bouvenot, Gilles ^c   Eschwège, Eveline ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICHAT HOSPITAL   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Antibiotic; Audit; Office based medical practice; Pharmacoepidemiology

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFADROXIL; CEFIXIME; CEFUROXIME; CEPHALOSPORIN; ISOPENICILLIN N; JOSAMYCIN; MACROLIDE; PENICILLIN G; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; SULFONAMIDE;

ARTICLE; FRANCE; HUMAN; MEDICAL AUDIT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TRACHEOBRONCHIAL TREE; VIRUS INFECTION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; DRUG UTILIZATION; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICAL AUDIT; OFFICE VISITS; OTITIS MEDIA; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; RESPIRATORY TRACT INFECTIONS;

EID: 0031983924     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00221-7     Document Type: Article

References (54)

1. Cohen ML Epidemiology of drug resistance. Implication for a post antimicrobial era Science. 257:1992;1050-1055.
2. Seppälä H, Klaukka T, Lehtonen R, Nenonen E, The Finnish Study Group for Antimicrobial Resistance, Huovinen P Outpatient use of erythromycin. Link to increased erythromycin resistance in group A streptococci Clin Infect Dis. 21:1995;1378-1385.
3. Nissinen A, Grönroos P, Huovinen P, Herva E, Katila M-L, Klaukka Tet al. Development of β-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis. 21:1995;1193-1196.
4. Geslin P Bêta-lactamines et pneumocoques multi-resistants isolés en France (1984-1994) Médecine et Hygiène. 53:1995;2111-2118.
5. Murray B Can antibiotic resistance be controlled? N Engl J Med. 330:1994;1229-1230.
6. Neu HC. The crisis in antibiotic resistance. Science 1992; 257(5073): 1064-1073.
7. Rosenberg J Methicillin-resistant Staphylococcus aureus in the community. Who's watching? Lancet. 346:1995;132-133.
8. Kunin CM, Lipton HL, Tupasi T, Sacks T, Scheckler WE, Jivani Aet al. Social, behavioral, and practical factors affecting antibiotic use worldwide. Report of Task Force 4 Rev Infect Dis. 9(Suppl. 3):1987;270-285.
9. Wilson ME Infectious disease. An ecological perspective Br Med J. 311:1995;1681-1684.
10. Kunin CM Antibiotic resistance - a world health problem we cannot ignore. Ann Intern Med. 99:1983;859-860. Editorial.
11. Burke JP, Levy SB Summary report of worldwide antibiotic resistance. International task force on antibiotic use Rev Infect Dis. 7:1985;560-564.
12. Baquero F, Martinez-Beltran J, Loza E A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother. 28:1991;31-38.
13. Arason V, Kristinsson K, Sigurdsson J, Stefansdottir G, Molstad S, Gudmundson S Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Br Med J. 313:1996;387-391.
14. Cometta A, Calandra T, Bille J, Glauser M Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med. 330:1994;1240-1241.
15. Datta N, Faiers M, Reeves D, Brumfitt W, Orskov F, Orskov I R-Factors in Escherichia coli in faeces after oral chemotherapy in general practice. Lancet. 1:1971;312-315.
16. Wyatt T, Ferguson W, Wilson T, McCormick E Gentamicin resistant Staphylococcus aureus associated with the use of topical gentamicin. J Antimicrob Chemother. 3:1977;213-217.
17. Kloos W Community structure of coagulase-negative staphylococci in humans. Shleissinger Microbiology 1986. 1986;132 American Society of Microbiology, Washington, DC.
18. Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroedan Fet al. Inappropriate Dosage of β-Lactams as a Risk-Factor of Penicillin-Resistant Streptococcus pneumoniae Carriage. 1996;American Society for Microbiology, 36th Icaac New Orleans. 9.
19. Levy SB Resistance to the tetracyclines. Bryan L Antimicrobial Drug Resistance. 1984;192-234 Academic Press, Orlando, FL.
20. Tenover FC, Hughes JM The challenges of emerging infectious diseases. JAMA. 275(4):1996;300-304.
21. Greenwood D Sixty years on. Antimicrobial drug resistance comes of age Lancet. 346(Suppl. 1):1995;1.
22. Kunin C Problems in antibiotic usage. Mandel G, Douglas RJ, Bennet J Principles and Practice of Infectious Diseases. 2:1985;John Wiley & Sons, New York.
23. Plouffe JF, Breiman RF, Facklam RR Bacteremia with Streptococcus pneumoniae. Implication for therapy and prevention JAMA. 275(3):1996;194-198.
24. Phelps CE Bug/drug resistance. Sometimes less is more Med Care. 27(2):1989;194-203.
25. Mandell GL, Bennett JE, Dolin R Principles and Practice of Infectious Diseases. 4:1995;Churchill Livingstone, New York.
26. Vangel MG Confidence intervals for a normal coefficient of variation. Am Stat. 50:1996;21-26.
27. Statistical Package for the Social Sciences [Macintosh program]. Version 4.0. Chicago: SPSS Inc.; 1990.
28. Gwaltney JJ Pharyngitis. Mandell GL, Bennet JE, Dolin R Principles and Practice of Infectious Diseases. 1995;566-572 Churchill Livingstone Inc, New York.
29. Veasy L, Wiedmeier S, Orsmond Get al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med. 316:1987;421-427.
30. Wallace M, Garst P, Papadimos T, Oldfield EI The return of acute rheumatic fever in young adults. JAMA. 262:1989;2557-2561.
31. Acute rheumatic fever among army trainees. MMWR. 37:1988;519-522.
32. Kaiser L, Lew D, Hirschel B, Auckenthaler R, Morabia A, Heald Aet al. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet. 347:1996;1507-1510.
33. Howie J, Clark G Double-blind trial of early dimethylchlortetracycline in minor respiratory illness in general practice. Lancet. ii:1970;1099-1102.
34. Stott NC, West RR Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J. 2:1976;556-559.
35. Williamson HA Jr. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract. 19:1984;481-486.
36. Brickfield FX, Carter WH, Johnson RE Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract. 23:1986;119-122.
37. Franks P, Gleiner J The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract. 19:1984;185-190.
38. Dunlay J, Reinhardt R, Roi LD A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract. 25:1987;137-141.
39. Verheij T, Hermans J, Mulder J Effect of doxycycline in patients with acute cough and purulent sputum. A double blind placebo controlled trial Br J Gen Pract. 44:1994;400-404.
40. Soyka L, Robinson D, Lachant N, Monaco J The misuse of antibiotics for treatment of upper respiratory tract infections in children. Pediatrics. 55:1975;552-555.
41. Jones P, Bigham RJ, Manning P Use of antibiotics in nonbacterial respiratory infections. JAMA. 153:1953;262-264.
42. Hoagland R, Deitz E, Myers P, Cosand C Aureomycin in the treatment of the common cold. N Engl J Med. 243:1950;773-775.
43. Hardy L, Traisman H Antibiotics and chemotherapeutic agents in the treatment of uncomplicated respiratory infections in children. J Pediatr. 50:1956;146-156.
44. Carbon C, Regnier B, Saimot G, Vilde JL, Yeni P Medicaments Antiinfectieux 1:1995;Flammarion, Paris.
45. Les infections ORL - 10eme Conférence de concensus en thérapeutique anti-infectieuse. La Lettre de l'Infectiologue 1996; 11: 578-582.
46. Glover J The incidence of tonsillectomy in school children. Proc R Soc Med. 31:1938;1219-1236.
47. Chassin M, Brook R, Park Ret al. Variations in the use of medical and surgical services by the Medicare population. N Engl J Med. 314:1986;285-290.
48. Maynard C, Fisher L, Alderman Eet al. Institutional differences in therapeutic decision making in the coronary artery surgery study. Med Dec Making. 6:1986;127-135.
49. Chassin M, Kosecoff J, Park R Does inappropriate use explain geographic variation in the use of health care services. A study of three procedures JAMA. 258:1987;2533-2537.
50. Wennberg JE, Mulley A, Hanley Det al. An assessment of prostectomy for benign urinary tract obstruction. Geographic variations and the evaluations of medical care outcomes JAMA. 259:1988;3027-3030.
51. Goyert G, Bottoms S, Treadwell M, Nephra P The physician factor in caesarian birth rates. N Engl J Med. 320:1989;706-709.
52. Poses RM, Wigton RS, Cebul RD, Centor RM, Collins M, Fleischli GJ Practice variation in the management of pharyngitis. The importance of variability in patients' clinical characteristics and in physicians' responses to them Med Decis Making. 13:1993;293-301.
53. Howie J, Bigg A Family trends in psychotropic and antibiotic prescribing in general practice. Br Med J. 280:1980;836-838.
54. Howie J. Clinical judgment and antibiotic use in general practice. Br Med J 1976; (ii): 1061-1064.